✦ LIBER ✦

MC13-0026 KRAS mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer

✍ Scribed by Spindler, K.; Appelt, L.A.; Pallisgaard, N.; Andersen, F.R.; Jakobsen, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KRAS-mutated plasma DNA as predictor of

✍ Spindler, K G; Appelt, A L; Pallisgaard, N; Andersen, R F; Jakobsen, A 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 171 KB

Quantitative Cell-Free DNA, KRAS, and BR

✍ Spindler, K.-L. G.; Pallisgaard, N.; Vogelius, I.; Jakobsen, A. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

471 KRAS, BRAF and PIK3Ca Mutations as P

✍ Spindler, K.G.; dePont Christensen, R.; Andersen, R.F.; Pallisgaard, N.; Johnson 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB